Welcome to the ePoster Viewing Panel of AICOG 2025

Innovating care : A pilot program examining carbetocin for post-partum hemrrohage control. Dr. Ankita Maurya , Dr.Avinashi Kujur Introduction : Each year, 14 million women experience PPH, causing 70,000 deaths globally, mostly in LMICs. In India, PPH affects 2%?4% of vaginal deliveries, contributing to 19.9% of maternal deaths, underscoring the urgent need for effective management to reduce mortality. AIM & OBJECTIVE: To access the efficacy of carbetocin in treatment of post-partum haemorrhage. Methods: A retrospective cohort study analyzing the efficacy of carbetocin as a first-line treatment for postpartum hemorrhage (PPH), focusing on its ability to control bleeding, need for additional uterotonics, surgical interventions, requirement for blood transfusions, and evaluate its impact on maternal morbidity and mortality. Results:?In our study involving 50 women with postpartum hemorrhage, all women were referrals from rural health care centers, received a 100mcg injection of carbetocin. Time is an essence in control of PPH , to save life. By using carbetocin effective uterine contraction was achieved within 2 mins and lasting upto 60mins. Significantly, we achieved 100% successful control of PPH. No additional uterotonics were needed and no surgical interventions were required. Out of 50 women, 11(22%) women required a transfusion of 1-2 units of blood, while 39 (78%)women did not need any transfusion. The use of carbetocin has led to a significant decrease in maternal mortality due to postpartum hemorrhage, reducing it from 90.97 deaths per 100,000 live births to zero as documented in our health facility. Conclusion: ?Carbetocin shows great promise as a rapid and effective treatment for postpartum hemorrhage. This medication could significantly reduce maternal morbidity and mortality, offering a new hope for mothers experiencing this life-threatening condition, by providing a swift response to hemorrhage. Keywords : Postpartum haemorrhage, uterine atony, carbetocin, maternal mortality